Breaking News

Cryoport Acquires Bluebird Express

Expands Cryoport's logistics solutions to U.S. and global life sciences clients.

Cryport, Inc., a global provider of innovative products and services to the fast-growing cell and gene therapy industry, acquired Bluebird Express, LLC, a provider of time-sensitive domestic and international transportation services. Bluebird Express will join Cryoport’s CRYOPDP business unit.

Valley Stream, NY-based Bluebird Express, has more than 20 years of experience in logistics solutions, specializing in domestic and international air and ground transportation. With key operations centers in Los Angeles and New York, Bluebird Express is a fully accredited cargo agent certified by the International Air Transport Association and an indirect air carrier (authorized and regulated by the Transportation Security Administration (TSA). Cryoport has had a strong working relationship with Bluebird Express since 2016.

Jerrell Shelton, CEO of Cryoport, said, “Bluebird Express’ competencies combined with CRYOPDP’s existing capabilities will allow us to offer an even greater array of end-to-end logistics solutions to both our U.S. and global life sciences clients. Additionally, Bluebird Express’ major operating centers in New York and Los Angeles, along with the expertise of its team will increase our U.S. footprint as well as further the expansion of our global infrastructure and competencies. The resulting synergies will create significant global cross-selling opportunities throughout our organization.”

“CRYOPDP has extensive experience in supporting the life sciences industry, including the rapidly growing market for cell and gene therapies,” said Cedric Picaud, CEO, CRYOPDP.” The United States has been leading the way in cell and gene therapy clinical trials since 2022, with over 400 companies actively developing cell and gene therapy products for various applications. The addition of Bluebird Express, whom already has an extensive working relationship with Cryoport, and its team of seasoned veterans will merge into CRYOPDP’s global network and will expand our U.S. presence and enhance our capabilities in this critical life sciences market and further enable us as we continue to deliver unparalleled service and value to our clients.”



  

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters